Skip to Main Content

Paper Details

Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma.
Journal of Medicinal Chemistry
7
2022
Glioblastoma, IDO1, IDO1 enzyme, IDO1 protein, Indoleamine, Indoleamine 2, Indoleamine 2,3-Dioxygenase 1, Indoleamine 2,3-dioxygenase 1, brain tumors, cancer, cereblon, cultured human glioblastoma (GBM) cells, glioblastoma, glioblastoma (GBM, human, intracranial brain tumors, mice, patients, tryptophan
Author NameAffiliation
Rintaro HashizumeRobert H. Lurie Comprehensive Cancer Center
Rintaro HashizumeNorthwestern University Feinberg School of Medicine
Charles D JamesNorthwestern University Feinberg School of Medicine
Craig HorbinskiNorthwestern University Feinberg School of Medicine
Craig HorbinskiRobert H. Lurie Comprehensive Cancer Center
Craig HorbinskiNorthwestern University Feinberg School of Medicine
  • 1 - 6

Datasets

Release 1.2